Introduction
vitro ACE inhibitory activity, having a mean inhibitory concentration (IC 50 ) of 0.32µM 66 (Zhou, Du, Ji, & Feng, 2012) . In addition, LKP has been shown to elicit a significant 67 reduction of blood pressure in spontaneously hypertensive rats (SHR) when delivered 68 intravenously, 10mg/kg -1 producing a reduction in systolic blood pressure of 75mmHg, 69 compared to an oral dose of 60mg/kg -1 , which resulted in a reduction of 18mmHg (Fujita, 70 Yokoyama, Yoshikawa, Iroyukifujita, & Eiichiyokoyama, 2000). Captopril, a synthetic oral 71 ACE inhibitor drug used for the treatment of hypertension, has been reported by Quiñones et 72 al. (2015) to show a maximum in vivo change in SHR of 60.5 ± 2.7 mmHg, 4 hours post-73 administration, when 50mg/kg was given orally . Recent studies have shown that LKP is 74 stable in the GIT but with lower permeation than the market drugs, across the intestine at its 75 target site, the small intestine (Gleeson, Heade, Ryan, & Brayden, 2015 The nanoparticle size (number distribution) and electrophoretic mobility measurements were 159 performed using folded capillary cells in a Nanosizer ZS fitted with a 633 nm laser (Malvern 160 Instruments Ltd.). Each analysis was carried out at 25°C with the equilibration time set to 2 161 min using size by intensity distribution. 162
Fourier transform infrared spectroscopy 163
The chemical properties of the NPs were monitored using Fourier transform infrared 164 spectroscopy (FT-IR), performed using a Perkin Elmer Spotlight 400 Series Spectrometer 165 (with Universal Attenuated total reflectance (ATR) accessory). FT-IR spectra of LKP, 166 unloaded NPs, and LKP NPs were obtained in the spectral range 650 to 4000 cm -1 in 167 triplicate. NP samples were stored at -80˚C in glass vials and then lyophilised prior to 168 analysis using a Labconco FreeZone 6 Liter Benchtop Freeze Dry System. 169
Scanning electron microscopy 170
The morphology of the freeze-dried NPs was studied using scanning electron microscopy 171 (SEM) (Hitachi SU6600 FESEM), at an accelerating voltage of 20kV using the secondary 172 electron detector. The freeze dried NPs (0.5mg) were dispersed in deionised water (10mL) 173 and sonicated for 4min. One drop of the dispersion containing LKP NPs was placed on a 174 silicon wafer and dried at room temperature. This was sputter coated with 4nm Au/Pd prior to 175 imaging. where C is the property (particle size or PDI) at time t, Co is the initial property conditions, k 221 is the apparent zero order reaction constant, E a is the energy of activation, R is the universalgas constant, T is the temperature of the experiment (K) and T ref is the reference temperature 223 (70°C). 224
MTS assay 225
Caco-2, heterogeneous human epithelial colorectal adenocarcinoma cells and HepG2, a 226 human liver cancer cell line, were seeded at a cell density of 2 x 10 4 cells/well and cultured 227 on 96 well plates in DMEM and EMEM respectively, supplemented with 10% fetal bovine 228 serum, 1% L -glutamine, 1% penicillin-streptomycin and 1% non-essential amino acids, and 229 incubated for 24h at 37°C in a humidified incubator with 5% CO 2 and 95% O 2 . Specified 230 exposure times were used for Caco-2 and HepG2, in order to mimic in vivo conditions. The 231 maximum time NPs will be exposed to the intestines are 4h, hence a 4h exposure time was An initial observation of the results at different ratios seems to indicate that the ratio of 5.9 is 291 the best performing in terms of higher AE% and lower PDI, while still maintaining a particle 292 size (150nm) and a ZP (>30mv) that indicates stability (figure 2). LC% for all experiments 293 showed no significant differences, values ranged from 2-3% (see supplementary material, S2) 294 were attained. Studies from other groups showed that an increase of counterion (TPP) 295 concentration results in a decrease of LC due to the high level of crosslinking, causing the 296 encapsulated material to come out of the particle (Woranuch & Yoksan, 2013) . to all responses and a minimum PDI. Analysis for all experimental results shows particle 303 sizes within the optimal size range (100-500nm) and ZP above 30mV values. However, for 304 some experimental conditions, the AE% and PDI exhibited values far from the optimal 305 physico-chemical characteristics and had high variability between replicates (N=3). At 306 (CLL113/TPP) ratios above 7 and below 4.5, the NPs exhibited higher PDI and, below a ratio 307 of 6, significant variability of AE% amongst replicates is evident. 308
The results obtained were consistent with those observed for unloaded CL113 NPs in terms 309 of particle size, although a significant increase in colloidal stability for the loaded NPs was 310 observed (see figure 3) . 311 The stability of formulations can be tested using a number of testing protocols, which include 391 real time stability testing, accelerated stability testing, retained sample stability testing and 392 cyclic temperature stress testing (Bajaj et al., 2012 ). In the current study, accelerated stability 393 testing was used, by which NPs are subjected to stress and then assayed simultaneously to 394 predict the likelihood of instability based upon the Arrhenius equation. Suspensions of NPs in 395 buffered solutions (PBS pH 7), formulated at a ratio of 5.9 CL113:TPP (optimal LKP loadedNPs), were exposed to three different storage temperatures, 60°C, 70°C and 80°C, over a 397 time course of 120, 300 and 720min at each temperature. Figure 6 shows the kinetic 398 behaviour of the particle sizes at different temperatures. The stability of the NPs decreased 399 with increasing temperature. At 60°C, no change in particle size was observed over the 400 720min. Figure 6 indicates a more pronounced increase in both particle size and PDI at 70°C, 401 while at 80°C, both particle size and PDI increase significantly over the time course. At this 402 temperature, the particle size was seen to increase monotonically from 200 to 600nm, while 403 the PDI increases from 0.4 to 0.7. While some curvature is apparent in the trends at the 404 highest temperature, within the present experimental error, an apparent zero order mechanism 405 fitted better to all the data, compared to an apparent first or second order model. 406 An Arrhenius plot of the apparent zero order reaction rate constants, derived from the 410 analysis of the individual experiments at the different temperatures, indicates that the kinetics 411 of the particle size and PDI followed this temperature relationship, consistent with an energy 412 activated process, with similar energies of activation for particle size and PDI (see Figure 7) . 413
The one-step nonlinear regression analysis of the kinetic experiments shows that the particle 414 size fits to a zero order kinetic behaviour and an Arrhenius dependence with ln (k ref@70C ) = -415 In addition, DD of CL113 used for this experiment is greater than 85%, it has been 441 previously reported that with an increase of DD the aggregation stability decreases due to the 442 CL113 more prone to TPP bridging which causes it to become more lyophobic near 443 physiological pH which may contribute to the stability of the NPs (Haung, Cai, & Lapitsky, 444 2015) . Overall, the accelerated experiments on LKP NPs indicate that the formulations will 445 be stable under normal storage conditions. This could be due to the conditions (presence of 446 salt) used to prepare the NPs, in addition to the strong bonding between the bioactive and 447 complex. The optimal NPs were found at a ratio 5.9:1 (CL113: TPP), using the design of experiment 517 approach, which resulted in reproducibility of the desirable physico-chemical characteristics. 518
Optimally LKP NPs were spheroidal particles of size ~200nm, as shown by SEM, and had 519 enhanced colloidal stability compared to the unloaded particles. A 5.9:1 ratio provided high 520 encapsulation efficiency of 65±3% with loading capacity of approximately 5±0.8 %. Stability 521 analysis showed long term physico-chemical stability. ACE inhibitory studies presented no 522 change in bioactivity of LKP over the different temperature conditions and after formulation 523 indicating it is quite stable. In addition, no cytotoxicity was observed from both the LKP 524 loaded and unloaded NPs. In vitro release studies indicated an initial burst within 1h, 525
suggesting the presence of more loosely bound tripeptide in the nanoparticle complex, 526 followed by peptide bounded within the nanoparticle which is released at a slower rate. 
